Nearly two-thirds of MS patients showed no signs of disability progression five years after having a stem cell transplant, a ...

U.S. and Chinese researchers appear to have unlocked a novel way to stop T cells from attacking the body in MS and other ...

Although it’s well-established that anti-CD20 therapies act mainly by killing B-cells, there hasn’t been much study on how these therapies may impact other cells in the immune system. To learn ...